Top Markets
Coin of the day
PhaseRx, Inc. PhaseRx, Inc.

PhaseRx, Inc.

PZRXQ
주식 순위 #42474
PhaseRx, Inc. is a biopharmaceutical company dedicated to developing treatments... PhaseRx, Inc. is a biopharmaceutical company dedicated to developing treatments for inherited enzyme deficiencies affecting the liver. Its therapeutic strategy involves intracellular enzyme replacement, powered by its unique Hybrid mRNA technology platform, which facilitates the production of absent enzymes directly within the body's cells. The company's pipeline includes several programs targeting urea cycle disorders, such as PRX-OTC for ornithine transcarbamylase deficiency, PRX-ASL for argininosuccinate lyase deficiency, and PRX-ASS1 for argininosuccinate synthetase deficiency. Established in 2006, PhaseRx is headquartered in Seattle, Washington.
주가
$0.0001
마지막 동기화: 2026-08-11
시가총액
$1.17K
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 PhaseRx, Inc. (PZRXQ)

카테고리

PhaseRx, Inc. (PZRXQ)의 주가 이력
최고 종가: $0.00 (2026-08-01 기준)

최저 종가: $5.21 (2016-05-01 기준)
PhaseRx, Inc.의 주가 이력 (2016 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) 0.00%
2025 -52.25%
2024 0.00%
2023 100.00%
2022 -4.35%
2021 -96.33%
2020 62.38%
2019 -37.88%
2018 -99.53%
2017 -62.39%
2016 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$527.87 36.13%
US
$873.57 37.02%
NL
$736.38 8.73%
CH
$263.09 20.45%
BE
$1.07K -5.56%
KR